Mrv0541 02231216472D 7 6 0 0 1 0 999 V2000 2.0625 0.7145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2375 0.7145 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.8250 1.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2375 2.1434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8250 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2375 -0.7145 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 6 0 0 0 2 3 1 0 0 0 0 3 4 2 0 0 0 0 2 5 1 0 0 0 0 5 6 1 0 0 0 0 5 7 2 0 0 0 0 M END > DB03214 > drugbank > N[C@@H](C=C)C(O)=O > InChI=1S/C4H7NO2/c1-2-3(5)4(6)7/h2-3H,1,5H2,(H,6,7)/t3-/m0/s1 > RQVLGLPAZTUBKX-VKHMYHEASA-N > C4H7NO2 > 101.1039 > 101.047678473 > 3 > 14 > -0.01095969212266501 > 9.648578916563805 > 1 > 2 > 0 > 0 > (2S)-2-aminobut-3-enoic acid > -2.74 > -2.465184833932763 > 0.39 > 0 > 0 > 0 > 0 > 2.422371811189335 > 8.952891990658918 > 63.32 > 24.9114 > 2 > 1 > 2.50e+02 g/l > tetrahydrofolic acid > 0 > DB03214 > EXPT02068 > experimental > Vinylglycine > (2S)-2-amino-3-butenoic acid; L-vinylglycine $$$$